Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial
一项 II 期临床试验表明,新型 devimistat 可使接受过大量治疗的 Burkitt 淋巴瘤患者获得完全缓解。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025016168
Steiner, Raphael; Nikolaenko, Liana; Nair, Ranjit; Seshan, Venkatraman; Thiruvengadam, Swetha Kambhampati; Khan, Niloufer; Abramson, Jeremy S; Horwitz, Steven; Matasar, Matthew; Owens, Colette; Rodriguez Rivera, Ildefonso Ismael; Straus, David J; Pardee, Timothy S; Luther, Sanjeev; Saboukoulou, Sabrina; Thet, Win Su; Vemuri, Shreya; Noy, Ariela